Cargando…

New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463

Senescent cells accumulate with aging and at sites of pathology in multiple chronic diseases. Senolytics are drugs that selectively promote apoptosis of senescent cells by temporarily disabling the pro-survival pathways that enable senescent cells to resist the pro-apoptotic, pro-inflammatory factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yi, Doornebal, Ewald J., Pirtskhalava, Tamar, Giorgadze, Nino, Wentworth, Mark, Fuhrmann-Stroissnigg, Heike, Niedernhofer, Laura J., Robbins, Paul D., Tchkonia, Tamara, Kirkland, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391241/ https://www.ncbi.nlm.nih.gov/pubmed/28273655 http://dx.doi.org/10.18632/aging.101202

Ejemplares similares

Effect of Combined Dasatinib and Fisetin Treatment on Senescent Cell Clearance in Monkeys
por: Colman, Ricki, et al.
Publicado: (2020)

Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016)

Fisetin is a senotherapeutic that extends health and lifespan
por: Yousefzadeh, Matthew J., et al.
Publicado: (2018)

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X(L) Inhibitor
por: Wang, Le, et al.
Publicado: (2020)

COVID-19 and cellular senescence
por: Schmitt, Clemens A., et al.
Publicado: (2022)

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
por: Tripathi, Utkarsh, et al.
Publicado: (2021)

Targeting senescent cells enhances adipogenesis and metabolic function in old age
por: Xu, Ming, et al.
Publicado: (2015)

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
por: Zhu, Yi, et al.
Publicado: (2015)

Cellular senescence mediates fibrotic pulmonary disease
por: Schafer, Marissa J., et al.
Publicado: (2017)

Deleted in Breast Cancer 1 Limits Adipose Tissue Fat Accumulation and Plays a Key Role in the Development of Metabolic Syndrome Phenotype
por: Escande, Carlos, et al.
Publicado: (2015)

Deleted in Breast Cancer 1 regulates cellular senescence during obesity
por: Escande, Carlos, et al.
Publicado: (2014)

Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era
por: Verdoorn, Brandon P., et al.
Publicado: (2021)

Identification of HSP90 inhibitors as a novel class of senolytics
por: Fuhrmann-Stroissnigg, Heike, et al.
Publicado: (2017)

Targeting cellular senescence in metabolic disease
por: Palmer, Allyson K., et al.
Publicado: (2022)

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

A chronic wound model to investigate skin cellular senescence
por: Wyles, Saranya P., et al.
Publicado: (2023)

Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
por: Ogrodnik, Mikolaj, et al.
Publicado: (2019)

Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
por: Ogrodnik, Mikolaj, et al.
Publicado: (2019)

ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
por: Zhu, Yi, et al.
Publicado: (2022)

Aging, Depot Origin, and Preadipocyte Gene Expression
por: Cartwright, Mark J., et al.
Publicado: (2010)

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice
por: Xu, Ming, et al.
Publicado: (2017)

Cellular Senescence: A Translational Perspective
por: Kirkland, James L., et al.
Publicado: (2017)

Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
por: Rahman, Masum, et al.
Publicado: (2022)

New Perspectives for Fisetin
por: Grynkiewicz, Grzegorz, et al.
Publicado: (2019)

Fisetin: An anticancer perspective
por: Imran, Muhammad, et al.
Publicado: (2020)

Senolytics: Potential for Alleviating Diabetes and Its Complications
por: Palmer, Allyson K, et al.
Publicado: (2021)

Flavones and Flavone Glycosides from Salvia macrosiphon Boiss
por: Gohari, Ahmad Reza, et al.
Publicado: (2011)

Growth hormone in adipose dysfunction and senescence
por: Stout, Michael B., et al.
Publicado: (2015)

Precision-cut liver slices: a versatile tool to advance liver research
por: Palma, Elena, et al.
Publicado: (2018)

Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells
por: Xiao, Xue, et al.
Publicado: (2018)

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers
por: Samakkarnthai, Parinya, et al.
Publicado: (2023)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022)

Regulatory Effects of Fisetin on Microglial Activation
por: Chuang, Jing-Yuan, et al.
Publicado: (2014)

Application of Fisetin to the Quantitation of Serum Albumin
por: Park, Jung-Min, et al.
Publicado: (2020)

TNF‐α/IFN‐γ synergy amplifies senescence‐associated inflammation and SARS‐CoV‐2 receptor expression via hyper‐activated JAK/STAT1
por: Kandhaya‐Pillai, Renuka, et al.
Publicado: (2022)

Targeting senescent cells alleviates obesity‐induced metabolic dysfunction
por: Palmer, Allyson K., et al.
Publicado: (2019)

FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue
por: Zhang, Yingyi, et al.
Publicado: (2021)

Discovery, development, and future application of senolytics: theories and predictions
por: Wissler Gerdes, Erin O., et al.
Publicado: (2020)

Functional Characterization of a Flavone Synthase That Participates in a Kumquat Flavone Metabolon
por: Tian, Shulin, et al.
Publicado: (2022)

Flavones: Six Selected Flavones and Their Related Signaling Pathways That Induce Apoptosis in Cancer
por: Jeong, Se Hyo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9qbu5flj7d119hdjs41otkmch